Stock-Based Compensation (Details) (USD $) | 3 Months Ended | 6 Months Ended |
Jun. 30, 2014 | Jun. 30, 2013 | Jun. 30, 2014 | Jun. 30, 2013 |
Stock based compensation by job function [Line Items] | ' | | ' | | ' | | ' | |
Compensation expense related to the company's stock-based compensation plans | $29,500,000 | | $27,300,000 | | $65,100,000 | | $57,700,000 | |
Common Shares Available for Grant | 32,300,000 | | ' | | 32,300,000 | | ' | |
Stock Options/SARs and Employee Stock Purchase Plan (ESPP) Disclosures [Line Items] | ' | | ' | | ' | | ' | |
Stock-based compensation expense related to stock options, SAR and ESPP grants | 11,700,000 | | 10,400,000 | | 23,700,000 | | 20,800,000 | |
Share-Based Compensation Arrangement By Share Based Payment Award Stock Option/SARs, ESPP, Restricted Stock/Units and Performance Units/Stock [Abstract] | ' | | ' | | ' | | ' | |
Unrecognized compensation expense | 83,500,000 | | ' | | 83,500,000 | | ' | |
Weighted average period over which unrecognized compensation expense will be recognized (in years) | ' | | ' | | '2 years 2 months 12 days | | ' | |
Stock Options and SARs [Member] | ' | | ' | | ' | | ' | |
Weighted Average Fair Values And Valuation Assumptions Used To Value Stock Option/SARs, ESPP, and Performance Units/Stock Stock-Based Compensation [Abstract] | ' | | ' | | ' | | ' | |
Weighted Average Fair Value of Grants (price per share) | ' | | ' | | $27.68 | | $19.33 | |
Expected Volatility (in hundredths) | ' | | ' | | 35.15% | | 35.82% | |
Risk-Free Interest Rate (in hundredths) | ' | | ' | | 0.86% | | 0.48% | |
Dividend Yield (in hundredths) | ' | | ' | | 0.50% | | 0.60% | |
Expected Life (in years) | ' | | ' | | '5 years 2 months 12 days | | '5 years 6 months | |
Stock Options and SARs Rollforward [Abstract] | ' | | ' | | ' | | ' | |
Outstanding at January 1 (in shares) | ' | | ' | | 10,452,000 | | 12,438,000 | |
Granted (in shares) | ' | | ' | | 74,000 | | 62,000 | |
Exercised (1) (in shares) | ' | | ' | | -922,000 | [1] | -1,938,000 | [1] |
Forfeited (in shares) | ' | | ' | | -185,000 | | -112,000 | |
Outstanding at June 30 (2) (in shares) | 9,419,000 | [2] | 10,450,000 | [2] | 9,419,000 | [2] | 10,450,000 | [2] |
Share-Based Compensation Arrangement By Share Based Payment Award Stock Option/SARs, ESPP, Restricted Stock/Units and Performance Units/Stock [Abstract] | ' | | ' | | ' | | ' | |
Outstanding at January 1 (price per share) | ' | | ' | | $54.43 | | $42.91 | |
Granted (price per share) | ' | | ' | | $92.51 | | $62.80 | |
Exercised (1) (price per share) | ' | | ' | | $43.76 | [1] | $32.81 | [1] |
Forfeited (price per share) | ' | | ' | | $62.02 | | $48.02 | |
Outstanding at June 30 (2) (price per share) | $55.62 | [2] | $44.85 | [2] | $55.62 | [2] | $44.85 | [2] |
Stock Options and SARs Vested or Expected to Vest (in shares) | 8,985,000 | [3] | 9,994,000 | [3] | 8,985,000 | [3] | 9,994,000 | [3] |
Weighted average grant price for stock options/SARs vested or expected to vest (price per share) | $55.22 | [3] | $44.67 | [3] | $55.22 | [3] | $44.67 | [3] |
Stock Options and SARs Exercisable at June 30 (in shares) | 3,898,000 | [4] | 4,510,000 | [4] | 3,898,000 | [4] | 4,510,000 | [4] |
Stock Options and SARs Exercisable at June 30 (price per share) | $44.71 | [4] | $39.99 | [4] | $44.71 | [4] | $39.99 | [4] |
Intrinsic value of stock options/SARs exercised during the period | ' | | ' | | 52,500,000 | | 62,100,000 | |
Aggregate intrinsic value for outstanding stock options and SARs | 576,800,000 | | 219,500,000 | | 576,800,000 | | 219,500,000 | |
Weighted average remaining contractual life for stock options/SARs outstanding (in years) | ' | | ' | | '4 years 2 months 12 days | | '4 years 1 month 6 days | |
Aggregate intrinsic value of stock options/SARs vested or expected to vest | 553,800,000 | | 211,700,000 | | 553,800,000 | | 211,700,000 | |
Weighted average remaining contractual life for stock options/SARs vested or expected to vest (in years) | ' | | ' | | '4 years 2 months 12 days | | '4 years 1 month 6 days | |
Aggregate intrinsic value for exercisable units | 281,300,000 | | 116,700,000 | | 281,300,000 | | 116,700,000 | |
Weighted average remaining contractual life for exercisable options/SARs (in years) | ' | | ' | | '2 years 9 months 18 days | | '2 years 7 months 6 days | |
ESPP [Member] | ' | | ' | | ' | | ' | |
Weighted Average Fair Values And Valuation Assumptions Used To Value Stock Option/SARs, ESPP, and Performance Units/Stock Stock-Based Compensation [Abstract] | ' | | ' | | ' | | ' | |
Weighted Average Fair Value of Grants (price per share) | ' | | ' | | $18.30 | | $14.40 | |
Expected Volatility (in hundredths) | ' | | ' | | 25.83% | | 29.95% | |
Risk-Free Interest Rate (in hundredths) | ' | | ' | | 0.09% | | 0.12% | |
Dividend Yield (in hundredths) | ' | | ' | | 0.40% | | 0.60% | |
Expected Life (in years) | ' | | ' | | '6 months | | '6 months | |
Restricted Stock and Restricted Stock Units [Member] | ' | | ' | | ' | | ' | |
Share-Based Compensation Arrangement By Share Based Payment Award Stock Option/SARs, ESPP, Restricted Stock/Units and Performance Units/Stock [Abstract] | ' | | ' | | ' | | ' | |
Unrecognized compensation expense | 148,500,000 | | ' | | 148,500,000 | | ' | |
Weighted average period over which unrecognized compensation expense will be recognized (in years) | ' | | ' | | '2 years 1 month 6 days | | ' | |
Share-Based Compensation Arrangement By Restricted Stock And Restricted Stock Units Compensation Cost | 16,800,000 | | 16,600,000 | | 39,500,000 | | 36,300,000 | |
Restricted Stock/Restricted Stock Units and Performance Units/Performance Stock [Roll Forward] | ' | | ' | | ' | | ' | |
Outstanding at January 1 (in shares) | ' | | ' | | 7,358,000 | | 7,636,000 | |
Granted (in shares) | ' | | ' | | 435,000 | | 530,000 | |
Released (in shares) | ' | | ' | | -1,939,000 | [5] | -586,000 | [5] |
Forfeited (in shares) | ' | | ' | | -181,000 | | -108,000 | |
Outstanding at June 30 (1) (in shares) | 5,673,000 | [6] | 7,472,000 | [6] | 5,673,000 | [6] | 7,472,000 | [6] |
Weighted Average Grant Price Restricted Stock and Restricted Stock Units/Performance Units and Performance Stock [Roll Forward] | ' | | ' | | ' | | ' | |
Outstanding at January 1 (price per share) | ' | | ' | | $49.54 | | $45.53 | |
Granted (price per share) | ' | | ' | | $94.73 | | $64.25 | |
Released (price per share) | ' | | ' | | $36.85 | [5] | $61.82 | [5] |
Forfeited (price per share) | ' | | ' | | $58.48 | | $47.20 | |
Outstanding at June 30 (1) (price per share) | $57.06 | [6] | $45.56 | [6] | $57.06 | [6] | $45.56 | [6] |
Intrinsic value of restricted stock and restricted stock units released during the year | ' | | ' | | 207,000,000 | | 35,400,000 | |
Aggregate intrinsic value of stock and units outstanding | 662,900,000 | | 491,900,000 | | 662,900,000 | | 491,900,000 | |
Performance Units and Performance Stock [Member] | ' | | ' | | ' | | ' | |
Share-Based Compensation Arrangement By Share Based Payment Award Stock Option/SARs, ESPP, Restricted Stock/Units and Performance Units/Stock [Abstract] | ' | | ' | | ' | | ' | |
Unrecognized compensation expense | 4,300,000 | | ' | | 4,300,000 | | ' | |
Weighted average period over which unrecognized compensation expense will be recognized (in years) | ' | | ' | | '1 year 10 months 24 days | | ' | |
Restricted Stock/Restricted Stock Units and Performance Units/Performance Stock [Roll Forward] | ' | | ' | | ' | | ' | |
Outstanding at January 1 (in shares) | ' | | ' | | 261,000 | | 143,000 | |
Granted (in shares) | ' | | ' | | 0 | | 0 | |
Released (in shares) | ' | | ' | | 0 | | 0 | |
Forfeited (in shares) | ' | | ' | | 0 | | 0 | |
Outstanding at June 30 (1) (in shares) | 261,000 | [7] | 143,000 | [7] | 261,000 | [7] | 143,000 | [7] |
Weighted Average Grant Price Restricted Stock and Restricted Stock Units/Performance Units and Performance Stock [Roll Forward] | ' | | ' | | ' | | ' | |
Outstanding at January 1 (price per share) | ' | | ' | | $82.18 | | $67.05 | |
Granted (price per share) | ' | | ' | | $0 | | $0 | |
Released (price per share) | ' | | ' | | $0 | | $0 | |
Forfeited (price per share) | ' | | ' | | $0 | | $0 | |
Outstanding at June 30 (1) (price per share) | $82.18 | [7] | $67.05 | [7] | $82.18 | [7] | $67.05 | [7] |
Aggregate intrinsic value of stock and units outstanding | 30,500,000 | | 9,400,000 | | 30,500,000 | | 9,400,000 | |
Performance Units and Performance Stock [Abstract] | ' | | ' | | ' | | ' | |
Share-Based Compensation Arrangement By Performance Units and Performance Stock Compensation Cost | 1,000,000 | | 300,000 | | 1,900,000 | | 600,000 | |
Lease And Well [Member] | ' | | ' | | ' | | ' | |
Stock based compensation by job function [Line Items] | ' | | ' | | ' | | ' | |
Compensation expense related to the company's stock-based compensation plans | 9,100,000 | | 8,400,000 | | 20,700,000 | | 18,200,000 | |
Gathering And Processing Costs [Member] | ' | | ' | | ' | | ' | |
Stock based compensation by job function [Line Items] | ' | | ' | | ' | | ' | |
Compensation expense related to the company's stock-based compensation plans | 200,000 | | 300,000 | | 500,000 | | 600,000 | |
Exploration Costs [Member] | ' | | ' | | ' | | ' | |
Stock based compensation by job function [Line Items] | ' | | ' | | ' | | ' | |
Compensation expense related to the company's stock-based compensation plans | 5,600,000 | | 6,400,000 | | 13,500,000 | | 13,900,000 | |
General And Administrative [Member] | ' | | ' | | ' | | ' | |
Stock based compensation by job function [Line Items] | ' | | ' | | ' | | ' | |
Compensation expense related to the company's stock-based compensation plans | $14,600,000 | | $12,200,000 | | $30,400,000 | | $25,000,000 | |
|
[1] | (1)The total intrinsic value of stock options/SARs exercised for the six months ended JuneB 30, 2014 and 2013 was $52.5 million and $62.1 million, respectively. The intrinsic value is based upon the difference between the market price of EOG's common stock on the date of exercise and the grant price of the stock options/SARs. |
[2] | (2)The total intrinsic value of stock options/SARs outstanding at JuneB 30, 2014 and 2013 was $576.8 million and $219.5 million, respectively. At JuneB 30, 2014 and 2013, the weighted average remaining contractual life was 4.2 years and 4.1 years, respectively. |
[3] | (3)The total intrinsic value of stock options/SARs vested or expected to vest at JuneB 30, 2014 and 2013 was $553.8 million and $211.7 million, respectively. At JuneB 30, 2014 and 2013, the weighted average remaining contractual life was 4.2 years and 4.1 years, respectively. |
[4] | (4)The total intrinsic value of stock options/SARs exercisable at JuneB 30, 2014 and 2013 was $281.3 million and $116.7 million, respectively. At JuneB 30, 2014 and 2013, the weighted average remaining contractual life was 2.8 years and 2.6 years, respectively. |
[5] | (1)The total intrinsic value of restricted stock and restricted stock units released for the six months ended JuneB 30, 2014 and 2013 was $207.0 million and $35.4 million, respectively. The intrinsic value is based upon the closing price of EOG's common stock on the date restricted stock and restricted stock units are released. |
[6] | (2)The total intrinsic value of restricted stock and restricted stock units outstanding at JuneB 30, 2014 and 2013 was $662.9 million and $491.9 million, respectively. |
[7] | (1)The total intrinsic value of performance units and performance stock outstanding at JuneB 30, 2014 and 2013 was $30.5 million and $9.4 million, respectively. |